首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and SAR evaluation of coumarin derivatives as potent cannabinoid receptor agonists
【24h】

Synthesis and SAR evaluation of coumarin derivatives as potent cannabinoid receptor agonists

机译:香豆素衍生物作为有效大麻素受体激动剂的合成及SAR评价

获取原文
获取原文并翻译 | 示例
           

摘要

We report the development and extensive structure-activity relationship evaluation of a series of modified coumarins as cannabinoid receptor ligands. In radioligand, and [S-35]GTP gamma S binding assays the CB receptor binding affinities and efficacies of the new ligands were determined. Furthermore, we used a ligand-based docking approach to validate the empirical observed results. In conclusion, several crucial structural requirements were identified. The most potent coumarins like 3-butyl-7-(1-butylcyclopentyl)-5-hydroxy-2H-chromen-2-one (36b, K-i CB2 13.7 nM, EC50 18 nM), 7-(1-butylcyclohexyl)-5-hydroxy-3-propyl-2H-chromen-2-one (39b, K-i CB2 6.5 nM, EC50 4.51 nM) showed a CB2 selective agonistic profile with low nanomolar affinities. (C) 2021 Published by Elsevier Masson SAS.
机译:我们报道了一系列改性香豆素作为大麻素受体配体的开发和广泛的构效关系评估。在放射性配体和[S-35]GTPγS结合试验中,测定了新配体的CB受体结合亲和力和效力。此外,我们使用基于配体的对接方法来验证经验观察结果。总之,确定了几个关键的结构要求。最有效的香豆素类化合物如3-丁基-7-(1-丁基环戊基)-5-羟基-2H-铬-2-酮(36b,K-i CB2 13.7 nM,EC50 18 nM),7-(1-丁基环己基)-5-羟基-3-丙基-2H-铬-2-酮(39b,K-i CB2 6.5 nM,EC50 4.51 nM)显示出具有低纳摩尔亲和力的CB2选择性激动剂谱。(c)2021由爱思唯尔马松SAS出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号